SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
TG Therapeutics, Inc. Announces Exclusive Licensing Agreement With Ildong Pharmaceutical Co., Ltd. for Development and Commercialization of Ublituximab (TGTX-1101) in South Korea and Southeast Asia